| Literature DB >> 11807774 |
Astrid Lanoue1, Facundo D Batista, Mairi Stewart, Michael S Neuberger.
Abstract
CD22 is a glycoprotein that associates with the B cell antigen receptor and acts as a negative regulator of receptor signaling; its extracellular domain binds alpha2,6-linked sialoglycoconjugates. Here we show that B cell activation by antigen displayed on the surface of a target cell is depressed if the target co-expresses alpha2,6-sialoglycoconjugates: this inhibition is dependent on CD22. Since sialylation is largely a feature of higher eukaryotes with alpha2,6-sialyltransferase increasing during inflammation, we propose that the CD22 / sialoglycoconjugate interaction allows context-dependent B cell activation, possibly acting as a crude discriminator of self in order to dampen B cell autoreactivity and the initiation of autoimmunity.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11807774 DOI: 10.1002/1521-4141(200202)32:2<348::AID-IMMU348>3.0.CO;2-5
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532